Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel
Journal cover image

MDM2 gene promoter polymorphisms and risk of lung cancer: a case-control analysis.

Publication ,  Journal Article
Li, G; Zhai, X; Zhang, Z; Chamberlain, RM; Spitz, MR; Wei, Q
Published in: Carcinogenesis
October 2006

The MDM2 protein negatively regulates p53 expression level in modulating DNA repair, cell-cycle control, cell growth and apoptosis. Polymorphisms in the promoter region of the MDM2 gene have been shown to alter protein expression and may, thus, play a role in carcinogenesis. To test our hypothesis that the MDM2 promoter polymorphisms are associated with risk of lung cancer, we conducted a hospital-based, case-control study of 1026 non-Hispanic white patients newly diagnosed with lung cancer and 1145 cancer-free controls who were frequency-matched by age (+/-5 years), sex, ethnicity and smoking status. We genotyped for the MDM2 promoter G2580T (also called SNP309) and G2164A polymorphisms that have a minor allele frequency >0.05. The distributions of the MDM2-2580G variant allele and genotypes were significantly less common among the cases than among the controls (P = 0.038 and 0.045, respectively), but this was not evident for MDM2-2164G (P = 0.865 and 0.614, respectively). Compared with the MDM2-2580TT genotype, the MDM2-2580G variant genotypes were associated with a decreased risk of lung cancer [odds ratio = 0.81 and 95% confidence interval = 0.67-0.98 for GT, 0.83 (0.63-1.08) for GG, and 0.81 (0.68-0.97) for the combined GT/GG genotype]. However, no significant association was observed between the MDM2-2164G variant genotypes and lung cancer risk. Our results suggest that the MDM2-2580G allele may be a marker of reduced genetic susceptibility to lung cancer in the non-Hispanic white population, a finding that seems to contradict previous reports.

Duke Scholars

Published In

Carcinogenesis

DOI

ISSN

0143-3334

Publication Date

October 2006

Volume

27

Issue

10

Start / End Page

2028 / 2033

Location

England

Related Subject Headings

  • Proto-Oncogene Proteins c-mdm2
  • Promoter Regions, Genetic
  • Polymorphism, Genetic
  • Oncology & Carcinogenesis
  • Middle Aged
  • Male
  • Lung Neoplasms
  • Humans
  • Genotype
  • Genetic Predisposition to Disease
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Li, G., Zhai, X., Zhang, Z., Chamberlain, R. M., Spitz, M. R., & Wei, Q. (2006). MDM2 gene promoter polymorphisms and risk of lung cancer: a case-control analysis. Carcinogenesis, 27(10), 2028–2033. https://doi.org/10.1093/carcin/bgl047
Li, Guojun, Xiaodong Zhai, Zhengdong Zhang, Robert M. Chamberlain, Margaret R. Spitz, and Qingyi Wei. “MDM2 gene promoter polymorphisms and risk of lung cancer: a case-control analysis.Carcinogenesis 27, no. 10 (October 2006): 2028–33. https://doi.org/10.1093/carcin/bgl047.
Li G, Zhai X, Zhang Z, Chamberlain RM, Spitz MR, Wei Q. MDM2 gene promoter polymorphisms and risk of lung cancer: a case-control analysis. Carcinogenesis. 2006 Oct;27(10):2028–33.
Li, Guojun, et al. “MDM2 gene promoter polymorphisms and risk of lung cancer: a case-control analysis.Carcinogenesis, vol. 27, no. 10, Oct. 2006, pp. 2028–33. Pubmed, doi:10.1093/carcin/bgl047.
Li G, Zhai X, Zhang Z, Chamberlain RM, Spitz MR, Wei Q. MDM2 gene promoter polymorphisms and risk of lung cancer: a case-control analysis. Carcinogenesis. 2006 Oct;27(10):2028–2033.
Journal cover image

Published In

Carcinogenesis

DOI

ISSN

0143-3334

Publication Date

October 2006

Volume

27

Issue

10

Start / End Page

2028 / 2033

Location

England

Related Subject Headings

  • Proto-Oncogene Proteins c-mdm2
  • Promoter Regions, Genetic
  • Polymorphism, Genetic
  • Oncology & Carcinogenesis
  • Middle Aged
  • Male
  • Lung Neoplasms
  • Humans
  • Genotype
  • Genetic Predisposition to Disease